Want to see ACTG full AI Analyst Report?
Top Page
Acacia Research
(NASDAQ:ACTG)
Select Model
Select Model
Rating:62Neutral
Price Target:
$5.00
▼(-0.40% Downside)
Action:Reiterated
Date:06/26/26
The score is primarily supported by financial resilience (very low leverage and positive TTM free cash flow), but is held back by weak and volatile profitability (TTM net loss and sharp revenue decline). The latest earnings call adds cautious support due to improving operated-segment performance and identifiable catalysts, while technical indicators remain largely neutral and valuation is pressured by negative earnings.
Positive Factors
Balance Sheet Strength
A very low debt-to-equity ratio (~0.02) and sizable equity base give Acacia durable financial flexibility. Low leverage reduces refinancing and solvency risk, enabling the company to fund litigation, capex, or acquisitions without pressing capital markets, a lasting advantage during IP revenue volatility.
Negative Factors
Episodic IP Revenue
Patent monetization remains lumpy and unpredictable; the collapse from $70M to $0.7M year-over-year shows settlements drive outsized swings. This structural dependency on episodic IP events undermines revenue predictability, margins, and long-term planning unless offset by recurring businesses.
Read all positive and negative factors
Positive Factors
Negative Factors
Balance Sheet Strength
A very low debt-to-equity ratio (~0.02) and sizable equity base give Acacia durable financial flexibility. Low leverage reduces refinancing and solvency risk, enabling the company to fund litigation, capex, or acquisitions without pressing capital markets, a lasting advantage during IP revenue volatility.
Read all positive factors
Acacia Research (ACTG) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$450.11M
Dividend YieldN/A
Average Volume (3M)146.16K
Price to Earnings (P/E)―
Beta (1Y)0.65
Revenue Growth-3.31%
EPS Growth-73.22%
CountryUS
Employees1,036
SectorIndustrials
Sector Strength72
IndustrySpecialty Business Services
Share Statistics
EPS (TTM)-0.18
Shares Outstanding96,589,134
10 Day Avg. Volume149,947
30 Day Avg. Volume146,158
Financial Highlights & Ratios
PEG Ratio-0.10
Price to Book (P/B)0.66
Price to Sales (P/S)1.26
P/FCF Ratio6.15
Enterprise Value/Market Cap0.56
Enterprise Value/Revenue1.17
Enterprise Value/Gross Profit1.19
Enterprise Value/Ebitda7.92
Forecast
1Y Price Target
$6.00Price Target Upside19.52% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)-0.36
Revenue Forecast (FY)$194.24M
Acacia Research Business Overview & Revenue Model
Company Description
Acacia Research Corporation, together with its associated entities, primarily concentrates on acquiring intellectual property and related high-yield assets. A core aspect of its business strategy involves the commercialization and defense of paten...
How the Company Makes Money
Acacia primarily makes money by monetizing patent rights. Its key revenue streams typically include (1) patent license fees and royalties paid by companies that agree to use the patented technology under a license, and (2) settlements and court-aw...
Acacia Research Earnings Call Summary
Earnings Call Date:May 07, 2026
(Q1-2026)
| % Change Since: |
Next Earnings Date:Aug 06, 2026
Earnings Call Sentiment Neutral
The call presented a mixed picture: operational execution and strategic investments showed tangible progress (Benchmark well success with strong returns, record production, Deflecto consolidation and expected cost savings, Printronix cash generation, and a solid liquidity position). However, material near-term negatives—chiefly an episodic collapse in IP revenue compared with the prior year and a large noncash unrealized hedge loss—drove a GAAP loss, lowered book value, and produced an adjusted net loss for the quarter. Management emphasized that many negatives are noncash or episodic (hedge mark-to-market and timing of IP settlements) and highlighted expected contributions from recently completed investments beginning in Q2 and H2 2026.Positive Updates
Total Q1 Revenue
Acacia reported total Q1 2026 revenue of $54.2 million.
Negative Updates
GAAP Net Loss Driven by Hedge Mark-to-Market
GAAP net loss attributable to Acacia was $15.7 million (negative $0.16 per share) versus net income of $24.3 million ($0.25 per share) in the prior-year quarter. A large driver was derivative hedge activity: total loss on hedges was $10.7 million (including $1.0 million realized and $9.7 million unrealized), which significantly impacted GAAP results and book value.
Read all updates
Q1-2026 Updates
Positive
Negative
Total Q1 Revenue
Acacia reported total Q1 2026 revenue of $54.2 million.
Read all positive updates
Company Guidance
Management guided that Q1 results set the stage for near‑term growth, reporting total Q1 revenue of $54.2M (operated revenue ex‑IP $53.5M), operated‑segment adjusted EBITDA of $10.3M (company adjusted EBITDA $1.6M) and GAAP net loss of $15.7M (‑$0.16/sh) while adjusted net loss was ‑$6.6M (‑$0.07/sh); Benchmark delivered record Q1 revenue $18.7M and $7.7M adjusted EBITDA, drilled its first Cherokee well with $11.5M development cost targeting >2.5x MOIC (~60%+ IRR) and expects production benefit in Q2–Q3 (April sales >63,000 barrels), noting ~75–80% of existing production hedged at ~ $70/bbl vs WTI $101/bbl (3/31) which produced a $9.7M unrealized hedge loss (~$0.10/sh noncash); Benchmark FCF was ‑$1.9M in Q1 (includes $8.5M CapEx; ex‑growth FCF >$6M); Deflecto showed sequential revenue +4.6% and adj. EBITDA +1.3%, completed Portland→Dover consolidation expected to save ~ $2M annually starting H2 (term loan balance $31.3M), Printronix generated ~$4.8M cash flow LTM (~15% cash‑flow yield), IP was $0.7M revenue with a ‑$3.5M adj. EBITDA, consolidated cash/securities/loans receivable $329.9M (down $9.7M q/q), total gross debt $90.5M (Benchmark $59.5M nonrecourse; Deflecto $31M nonrecourse), and parent adjusted G&A $5.2M — with management emphasizing growing EBITDA and free cash flow and pursuing accretive M&A.Acacia Research Financial Statement Overview
Summary
Income Statement
54
Neutral
Balance Sheet
83
Very Positive
Cash Flow
72
Positive
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 215.05M | 285.23M | 122.31M | 125.10M | 59.22M | 88.05M |
| Gross Profit | 210.26M | 235.22M | 29.65M | 72.27M | 21.84M | 51.95M |
| EBITDA | 31.64M | 83.65M | 2.85M | 84.33M | -107.20M | 193.26M |
| Net Income | -18.35M | 21.68M | -36.06M | 67.06M | -125.06M | 149.20M |
Balance Sheet | ||||||
| Total Assets | 755.87M | 770.96M | 756.39M | 633.54M | 482.93M | 798.86M |
| Cash, Cash Equivalents and Short-Term Investments | 327.53M | 330.09M | 333.76M | 439.91M | 386.14M | 707.47M |
| Total Debt | 103.26M | 104.67M | 124.33M | 13.51M | 63.88M | 184.21M |
| Total Liabilities | 188.65M | 186.92M | 203.78M | 43.94M | 213.61M | 368.38M |
| Stockholders Equity | 528.50M | 543.45M | 514.83M | 568.27M | 258.28M | 419.43M |
Cash Flow | ||||||
| Free Cash Flow | 52.42M | 58.55M | -112.55M | -28.70M | -43.07M | -7.76M |
| Operating Cash Flow | 76.22M | 75.24M | 50.12M | -22.51M | -37.34M | 13.33M |
| Investing Cash Flow | -23.03M | -21.01M | -212.96M | 16.18M | 184.46M | 35.75M |
| Financing Cash Flow | -18.56M | -22.73M | 97.56M | 58.63M | -166.14M | 59.74M |
Acacia Research Technical Analysis
Negative
5.02
Price Trends
4.77
Negative
4.65
Positive
4.12
Positive
Market Momentum
>-0.01
Negative
48.10
Neutral
22.51
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For ACTG, the sentiment is Negative. The current price of 5.02 is above the 20-day moving average (MA) of 4.70, above the 50-day MA of 4.77, and above the 200-day MA of 4.12, indicating a neutral trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 48.10 is Neutral, neither overbought nor oversold. The STOCH value of 22.51 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for ACTG.
Acacia Research Risk Analysis
Acacia Research disclosed 65 risk factors in its most recent earnings report. Acacia Research reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Acacia Research Peers Comparison
UnderperformOutperform
Sector (63)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | $450.11M | -24.99 | -3.42% | ― | -3.31% | -73.22% | |
55 Neutral | $902.80M | -5.02 | -18.29% | ― | 4.42% | -428.47% | |
55 Neutral | $33.61M | -13.16 | -6.40% | 7.58% | -100.00% | -5.04% | |
49 Neutral | $392.88M | 13.27 | 24.97% | 4.69% | -10.40% | ― | |
48 Neutral | $23.47M | -0.77 | -95.31% | ― | -18.24% | -169.43% | |
46 Neutral | $49.81M | -0.73 | 106.69% | ― | -65.57% | -254.11% |
* Industrials Sector Average
ACTG
Acacia Research
4.66
0.99
26.98%
OMEX
Odyssey Marine Exploration
0.85
-0.26
-23.42%
QUAD
Quad/Graphics
8.43
3.03
56.17%
SGRP
Spar Group
0.83
-0.15
-15.71%
KODK
Kodak
9.25
3.28
54.94%
NTIP
Network-1 Technologies
1.47
0.32
27.49%
Acacia Research Corporate Events
Executive/Board ChangesShareholder Meetings
Acacia Research Shareholders Back Directors and Governance Matters
Positive
Jun 25, 2026
At its June 23, 2026 virtual annual meeting, Acacia Research Corporation reported that 86,674,540 shares were represented, establishing a quorum, and stockholders elected five directors, including Gavin Molinelli, Michelle Felman, Isaac T. Kohlber...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.